Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial glucocorticoid deficiency in which the cause of the disease is a mutation in the MC2R gene.
Features include always present findings: Increased circulating ACTH level, Decreased circulating cortisol level, Abnormal response to ACTH stimulation test, and Generalized hyperpigmentation and others. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 2 | Tall stature, Failure to thrive |
MC2R encodes melanocortin 2 receptor (297 aa). G protein-coupled receptor for corticotropin/ACTH, primarily expressed in adrenal cortex where it plays a key role in the regulation of adrenocortical function. Highest expression in Adrenal Gland (44.6 TPM) and Pituitary (1.1 TPM).
Glucocorticoid deficiency 1 is associated with mutations in the MC2R gene on chromosome 18.
The MC2R protein participates in Defective ACTH does not bind MCR2, CYP11B1 oxidises 11DCORT, and SRD5A1 dehydrogenates TEST to DHTEST pathways.
MC2R is classified as a druggable target (Druggable Genome and G Protein Coupled Receptor categories) with score 13.1.
Genetic testing for MC2R is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 6 always present features.
No clinical trials have been registered for glucocorticoid deficiency 1.
9 publications have been identified in PubMed for glucocorticoid deficiency 1. Research spans Case Report / Case Series (67%), Review / Meta-Analysis (11%), and Basic Science / Preclinical (11%).
Singhal A (2026). [PMID: 41541841](https://pubmed.ncbi.nlm.nih.gov/41541841/). *JCEM Case Rep*. [Case Report / Case Series]
Karakilic Ozturan E (2025). [PMID: 39496238](https://pubmed.ncbi.nlm.nih.gov/39496238/). *Horm Res Paediatr*. [Basic Science / Preclinical]
Wang X (2025). [PMID: 40726908](https://pubmed.ncbi.nlm.nih.gov/40726908/). *Front Pediatr*. [Case Report / Case Series]
Bardhan M (2025). [PMID: 41002740](https://pubmed.ncbi.nlm.nih.gov/41002740/). *Diseases*. [Review / Meta-Analysis]
Sheya A (2025). [PMID: 40917321](https://pubmed.ncbi.nlm.nih.gov/40917321/). *Indian J Endocrinol Metab*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:02 PM UTC
Online Mendelian Inheritance in Man
Skin
2 |
Generalized hyperpigmentation, Hyperpigmentation of the skin |
Brain and nerves | 1 | Seizure |
Hormones | 1 | Decreased circulating cortisol level |
Lab test results | 1 | Decreased circulating cortisol level |
Blood and immune system | 1 | Recurrent infections |
Bones and joints | 1 | Accelerated skeletal maturation |
Age of onset: at birth.
Tresa A (2025). [PMID: 39956565](https://pubmed.ncbi.nlm.nih.gov/39956565/). *BMJ Case Rep*. [Case Report / Case Series]
Chougula PV (2025). [PMID: 40000035](https://pubmed.ncbi.nlm.nih.gov/40000035/). *BMJ Case Rep*. [Case Report / Case Series]
Maleknejad S (2024). [PMID: 39135905](https://pubmed.ncbi.nlm.nih.gov/39135905/). *Int J Endocrinol*. [Case Report / Case Series]